{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:33:07Z","timestamp":1795015987998,"version":"4.10.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Laboratory of The Diagnosis and Treatment of Severe Trauma and Burn of Zhejiang Province","award":["2022K04"],"award-info":[{"award-number":["2022K04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) demonstrates therapeutic efficacy in the management of traumatic brain injury (TBI). The objective of this systematic review and meta-analysis was to evaluate the safety and effectiveness of TXA in patients with TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The databases, namely PubMed, Embase, Web of Science, and Cochrane Library databases, were systematically searched to retrieve randomized controlled trials (RCTs) investigating the efficacy of TXA for TBI from January 2000 to November 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The present meta-analysis incorporates ten RCTs. Compared to the placebo group, administration of TXA in patients with TBI resulted in a significant reduction in mortality (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05), hemorrhage growth (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03), and volume of hemorrhage growth (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). However, no significant impact was observed on neurosurgery outcomes (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.25), seizure occurrence (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.78), or pulmonary embolism incidence (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.52).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The administration of TXA is significantly associated with reduced mortality and hemorrhage growth in patients suffering from TBI, while the need of neurosurgery, seizures, and incidence of pulmonary embolism remains comparable to that observed with placebo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13049-024-01188-z","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T11:02:33Z","timestamp":1709809353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic efficacy of tranexamic acid on traumatic brain injury: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"32","author":[{"given":"Jia-Xing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5316-1383","authenticated-orcid":false,"given":"Jian-Chun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"1188_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cct.2014.11.008","volume":"40","author":"J Lei","year":"2015","unstructured":"Lei J, Gao G, Mao Q, et al. Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial). Contemp Clin Trials. 2015;40:9\u201314.","journal-title":"Contemp Clin Trials"},{"key":"1188_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","volume":"16","author":"A Maas","year":"2017","unstructured":"Maas A, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16:987\u20131048.","journal-title":"Lancet Neurol"},{"key":"1188_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1089\/neu.2007.0385","volume":"25","author":"RK Narayan","year":"2008","unstructured":"Narayan RK, Maas AI, Servadei F, et al. Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma. 2008;25:629\u201339.","journal-title":"J Neurotrauma"},{"key":"1188_CR4","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.3171\/sup.1991.75.1s.0s28","volume":"75","author":"LF Marshall","year":"1991","unstructured":"Marshall LF, Gautille T, Klauber MR. The outcome of severe closed head injury. J Neurosurg. 1991;75:S28-36.","journal-title":"J Neurosurg"},{"key":"1188_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/00005373-198910000-00018","volume":"29","author":"SR Shackford","year":"1989","unstructured":"Shackford SR, Mackersie RC, Davis JW, et al. Epidemiology and pathology of traumatic deaths occurring at a level I trauma center in a regionalized system: the importance of secondary brain injury. J Trauma. 1989;29:1392\u20137.","journal-title":"J Trauma"},{"key":"1188_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00701-007-1475-8","volume":"150","author":"BS Harhangi","year":"2008","unstructured":"Harhangi BS, Kompanje EJ, Leebeek FW, et al. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008;150:165\u201375.","journal-title":"Acta Neurochir (Wien)"},{"key":"1188_CR7","first-page":"55","volume":"66","author":"P Talving","year":"2009","unstructured":"Talving P, Benfield R, Hadjizacharia P, et al. Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009;66:55\u201361.","journal-title":"J Trauma"},{"key":"1188_CR8","first-page":"CD004896","volume":"4","author":"T Coats","year":"2004","unstructured":"Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2004;4:CD004896.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1188_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","volume":"135","author":"L Tengborn","year":"2015","unstructured":"Tengborn L, Blomb\u00e4ck M, Berntorp E. Tranexamic acid: an old drug still going strong and making a revival. Thromb Res. 2015;135(2):231\u201342.","journal-title":"Thromb Res"},{"key":"1188_CR10","doi-asserted-by":"crossref","unstructured":"Kothari S, Gilbert-Baffoe E, O\u2019Brien KA. Disorders of Consciousness. In: Eapen BC, Cifu DX, editors. Rehabilitation After Traumatic Brain Injury. St. Louis: Elsevier; 2018; with permission.","DOI":"10.1016\/B978-0-323-54456-6.00014-1"},{"issue":"5","key":"1188_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/01.sla.0000256862.79374.31","volume":"245","author":"K Brohi","year":"2007","unstructured":"Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245(5):812\u20138.","journal-title":"Ann Surg"},{"issue":"1","key":"1188_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccc.2016.08.004","volume":"33","author":"RJ Ramirez","year":"2017","unstructured":"Ramirez RJ, Spinella PC, Bochicchio GV. Tranexamic acid update in trauma. Crit Care Clin. 2017;33(1):85\u201399.","journal-title":"Crit Care Clin"},{"issue":"1","key":"1188_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"issue":"4","key":"1188_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","volume":"45","author":"O Chakroun-Walha","year":"2019","unstructured":"Chakroun-Walha O, Samet A, Jerbi M, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2019;45(4):719\u201326.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"1188_CR15","doi-asserted-by":"crossref","unstructured":"CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH -3): a randomized, placebo-controlled trial. Lancet, 2019, 394(10210): 1713\u20131723.","DOI":"10.1016\/S0140-6736(19)32233-0"},{"issue":"4","key":"1188_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1574887114666190620112829","volume":"14","author":"P Ebrahimi","year":"2019","unstructured":"Ebrahimi P, Mozafari J, Ilkhchi RB, Hanafi MG, Mousavinejad M. Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2019;14(4):286\u201391.","journal-title":"Rev Recent Clin Trials"},{"key":"1188_CR17","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","volume":"109","author":"E Fakharian","year":"2018","unstructured":"Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748\u201353.","journal-title":"World Neurosurg"},{"issue":"1","key":"1188_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","volume":"20","author":"A Jokar","year":"2017","unstructured":"Jokar A, Ahmadi K, Salehi T, et al. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial. Chin J Traumatol. 2017;20(1):49\u201351.","journal-title":"Chin J Traumatol"},{"issue":"1","key":"1188_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1574887114666191118111826","volume":"15","author":"M Mousavinejad","year":"2020","unstructured":"Mousavinejad M, Mozafari J, Ilkhchi RB, Hanafi MG, Ebrahimi P. Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2020;15(1):70\u20135.","journal-title":"Rev Recent Clin Trials"},{"issue":"13","key":"1188_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16130","volume":"16","author":"P Perel","year":"2012","unstructured":"Perel P, Al-Shahi Salman R, Kawahara T, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury\u2014a nested randomised, placebo-controlled trial. Health Technol Assess. 2012;16(13):1\u201354.","journal-title":"Health Technol Assess"},{"issue":"10","key":"1188_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jama.2020.8958","volume":"324","author":"SE Rowell","year":"2020","unstructured":"Rowell SE, Meier EN, McKnight B, et al. Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA. 2020;324(10):961.","journal-title":"JAMA"},{"issue":"2","key":"1188_CR22","first-page":"223","volume":"31","author":"H Safari","year":"2021","unstructured":"Safari H, Farrahi P, Rasras S, et al. Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in traumatic brain injury. Turk Neurosurg. 2021;31(2):223\u20137.","journal-title":"Turk Neurosurg"},{"key":"1188_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-227X-13-20","volume":"13","author":"S Yutthakasemsunt","year":"2013","unstructured":"Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, et al. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13:20.","journal-title":"BMC Emerg Med"},{"key":"1188_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/01.TA.0000159249.68363.78","volume":"58","author":"MM Carrick","year":"2005","unstructured":"Carrick MM, Tyroch AH, Youens CA, et al. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma. 2005;58:725\u20139.","journal-title":"J Trauma"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1227\/00006123-198906000-00007","volume":"24","author":"JD Olson","year":"1989","unstructured":"Olson JD, Kaufman HH, Moake J, et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery. 1989;24:825\u201332.","journal-title":"Neurosurgery"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1385\/NCC:1:4:479","volume":"1","author":"SC Stein","year":"2004","unstructured":"Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. 2004;1:479\u201388.","journal-title":"Neurocrit Care"},{"key":"1188_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4103\/0028-3886.28106","volume":"54","author":"A Bayir","year":"2006","unstructured":"Bayir A, Kalkan E, Ko\u00e7ak S, et al. Fibrinolytic markers and neurologic outcome in traumatic brain injury. Neurol India. 2006;54:363\u20135.","journal-title":"Neurol India"},{"key":"1188_CR28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.STR.29.6.1202","volume":"29","author":"BE Figueroa","year":"1998","unstructured":"Figueroa BE, Keep RF, Betz AL, et al. Plasminogen activators potentiate thrombininduced brain injury. Stroke. 1998;29:1202\u20137.","journal-title":"Stroke"},{"key":"1188_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.12688\/wellcomeopenres.14700.2","volume":"3","author":"I Roberts","year":"2018","unstructured":"Roberts I, Belli A, Brenner A, et al. Tranexamic acid for signifcant traumatic brain injury (The CRASH-3 trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Wellcome Open Res. 2018;3:86.","journal-title":"Wellcome Open Res"},{"key":"1188_CR30","doi-asserted-by":"crossref","unstructured":"CRASH-3 intracranial bleeding mechanistic study collaborators. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial. Eur J Trauma Emerg Surg, 2021;47(1): 261\u2013268.","DOI":"10.1007\/s00068-020-01316-1"},{"issue":"1","key":"1188_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12883-020-01694-4","volume":"20","author":"J July","year":"2020","unstructured":"July J, Pranata R. Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury-meta-analysis of randomized controlled trials. BMC Neurol. 2020;20(1):119.","journal-title":"BMC Neurol"},{"issue":"1","key":"1188_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/TA.0000000000001726","volume":"84","author":"ME Diebel","year":"2018","unstructured":"Diebel ME, Martin JV, Liberati DM, et al. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation. J Trauma Acute Care Surg. 2018;84(1):75\u201380.","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"1188_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/HTR.0000000000000619","volume":"35","author":"TN Anderson","year":"2020","unstructured":"Anderson TN, Hinson HE, Dewey EN, et al. Early tranexamic acid administration after traumatic brain injury is associated with reduced syndecan-1 and angiopoietin-2 in patients with traumatic intracranial hemorrhage. J Head Trauma Rehabil. 2020;35(5):317\u201323.","journal-title":"J Head Trauma Rehabil"},{"issue":"16","key":"1188_CR34","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1182\/blood-2014-08-588442","volume":"125","author":"N Hijazi","year":"2015","unstructured":"Hijazi N, Abu Fanne R, Abramovitch R, et al. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice. Blood. 2015;125(16):2558\u201367.","journal-title":"Blood"},{"issue":"6","key":"1188_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/SHK.0000000000000912","volume":"48","author":"J Karri","year":"2017","unstructured":"Karri J, Cardenas JC, Matijevic N, et al. Early fibrinolysis associated with hemorrhagic progression following traumatic brain injury. Shock. 2017;48(6):644\u201350.","journal-title":"Shock"},{"key":"1188_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.wneu.2018.11.214","volume":"123","author":"S Weng","year":"2019","unstructured":"Weng S, Wang W, Wei Q, Lan H, Su J, Xu Y. Effect of tranexamic acid in patients with traumatic brain injury: a systematic review and meta-analysis. World Neurosurgery. 2019;123:128\u201335.","journal-title":"World Neurosurgery"},{"issue":"3","key":"1188_CR37","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10143-020-01324-0","volume":"44","author":"JL de Faria","year":"2021","unstructured":"de Faria JL, da Silva BJ, Silva CE, LT, et al. Tranexamic acid in neurosurgery: a controversy indication-review. Neurosurg Rev. 2021;44(3):1287\u201398.","journal-title":"Neurosurg Rev"}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-024-01188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13049-024-01188-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-024-01188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T10:07:10Z","timestamp":1722593230000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-024-01188-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1186\/s13049-024-01188-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3610267\/v1","asserted-by":"object"}]},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}